Molecular analysis of a spontaneous dystrophin 'knockout' dog

Neuromuscular Disorders

Volumn 9, Issue 5, 1999, Pages 289-295

  Schatzberg, Scott J ^a   Olby, Natasha J ^a   Breen, Matthew ^b   Anderson, Louise V B ^c   Langford, Cordelia F ^d   Dickens, Helen F ^b   Wilton, Stephen D ^e   Zeiss, Caroline J ^f   Binns, Matthew M ^b   Kornegay, Joe N ^g   Morris, Glenn E ^h   Sharp, Nicholas J H ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b ANIMAL HEALTH TRUST   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e Australian Neuromuscular Res Inst   (Australia)

^f Department of Obstetrics Gynecology   (United States)

^g UNIVERSITY OF MISSOURI   (United States)

^h GLYNDWR UNIVERSITY   (United Kingdom)

Author keywords

Animal models; Canine; Duchenne muscular dystrophy; Dystrophin; Fluorescence in situ hybridization; Polymerase chain reaction

Indexed keywords

DYSTROPHIN; PROTEIN P21; UTROPHIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CREATINE KINASE BLOOD LEVEL; CYTOGENETICS; DNA DETERMINATION; DOG; DUCHENNE MUSCULAR DYSTROPHY; GENE DELETION; HEART DILATATION; HISTOCHEMISTRY; IMMUNOBLOTTING; KNOCKOUT GENE; MALE; MUSCLE BIOPSY; MYOPATHY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKELETAL MUSCLE; TRICEPS BRACHII MUSCLE; X CHROMOSOME;

ANIMALS; BIOPSY; BLOTTING, WESTERN; CHROMOSOME DELETION; CREATINE KINASE; DISEASE MODELS, ANIMAL; DNA; DOG DISEASES; DOGS; DYSTROPHIN; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUTATION; POLYMERASE CHAIN REACTION; X CHROMOSOME;

EID: 0032966013     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(99)00011-5     Document Type: Article

References (49)

1. Monaco A., Walker A., Millwood I., Larin Z., Lehrach H. A yeast artificial chromosome contig containing the complete Duchenne muscular dystrophy gene. Genomics. 12:1992;465-473.
2. Boyce F., Beggs A., Feener C., Kunkel L. Dystrophin is transcribed in brain from a distant upstream promoter. Proc Natl Acad Sci USA. 88:1991;1276-1280.
3. Gorecki D., Monaco A., Derry J., Walker A., Barnard E., Barnard P. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet. 1:1992;505-510.
4. Klamut H., Gangopadhyay S., Worton R., Ray P. Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol Cell Biol. 10:1990;193-205.
5. den Dunnen J., Grootscholten P., Bakker E.et al. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet. 45:1989;835-847.
6. Kunkel L. Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature. 322:1986;73-77.
7. Beggs A., Koenig M., Boyce F., Kunkel L. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet. 86:1990;45-48.
8. Chamberlain J., Gibbs R., Ranier J., Nguyen P., Caskey C. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 16:1988;11141-11156.
9. Francke U., Ochs H., Giacalone J.et al. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet. 37:1985;250-267.
10. Clarke A., Roberts S., Thomas N., Whitfield A., Williams J., Harper P. Duchenne muscular dystrophy with adrenal insufficiency and glycerol kinase deficiency: high resolution cytogenetic analysis with molecular, biochemical, and clinical studies. J Med Genet. 23:1986;501-508.
11. Bartley J., Patil S., Davenport S., Goldstein D., Pickens J. Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal insufficiency associated with Xp21 interstitial deletion. J Pediatr. 108:1986;189-192.
12. Stuhrmann M., Heilbronner H., Reis A., Wegner R., Fischer P., Schmidtke J. Characterization of a Xp21 microdeletion syndrome in a 2-year-old boy with muscular dystrophy, glycerol kinase deficiency and adrenal hypoplasia congenita. Hum Genet. 86:1991;414-415.
13. Calvano S., Memeo E., Piemontese M.et al. Detection of dystrophin deletion carriers using FISH analysis. Clin Genet. 52:1997;17-22.
14. Voskova-Goldman A., Peier A., Caskey C., Richards C., Shaffer L. DMD-specific FISH probes are diagnostically useful in the detection of female carriers of DMD gene deletions. Neurology. 48:1997;1633-1638.
15. Sicinski P., Geng Y., Ryder-Cook A., Barnard E., Darlison M., Barnard P. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 244:1989;1578-1580.
16. Winand N., Edwards M., Pradhan D., Berian C., Cooper B. Deletion of the dystrophin muscle promoter in feline muscular dystrophy. Neuromuscul Disord. 4:1994;433-445.
17. Sharp N., Kornegay J., Van Camp S.et al. An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics. 13:1992;115-121.
18. Winand N, Pradham D, Cooper B. 'Molecular characterization of severe Duchenne-type muscular dystrophy in a family of rottweiler dogs' presented at Molecular mechanisms of neuromuscular disease, Tuscon, AZ, 1994.
19. Nicholson L., Davison K., Johnson M.et al. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci. 94:1989;137-146.
20. Nicholson L., Davison K., Falkous G.et al. Dystrophin in skeletal muscle. I. Western Blot analysis using a monoclonal antibody. J Neurol Sci. 94:1989;137-146.
21. Man Nt., Ellis J., Love D.et al. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol. 115:1991;1695-1700.
22. Schatzberg S, Olby N, Steingold S, et al. A polymerase chain reaction (PCR) screening strategy for the canine dystrophin promoter Am J Vet Res (in press).
23. Zeiss C., Acland G., Aguirre G., Ray K. Cloning of RPGR in a canine model of XLRP and characterization of novel splice variants. Invest Ophthalmol Vis Sci. 39:1998;4082.
24. Breen M., Arveiler B., Murray I., Gosden J., Porteous D. YAC mapping by FISH using Alu-PCR-generated probes. Genomics. 13:1992;726-730.
25. Moise N., Valentine B., Brown C.et al. Duchenne's cardiomyopathy in a canine model: electrocardiographic and echocardiographic studies. J Am Coll Cardiol. 17:1991;812-820.
26. Deschenes S., Puck J., Dutra A., Somberg R., Felsburg P., Henthorn P. Comparative mapping of canine and human proximal Xq and genetic analysis of canine X-linked severe combined immunodeficiency. Genomics. 23:1994;62-68.
27. Reimann N., Bartnitzke S., Bullerdiek J.et al. An extended nomenclature of the canine karyotype. Cytogenet Cell Genet. 73:1996;140-144.
28. Giovannini M., Selleri L., Biegel J., Scotlandi K., Emanuel B., Evans G. Interphase cytogenetics for the detection of the t(11;22) (q24;q12) in small round cell tumors. J Clin Invest. 90:1992;1911-1918.
29. Langford C., Fischer P., Binns M., Holmes N., Carter N. Chromosome-specific paints from a high-resolution flow karyotype of the dog. Chromosome Res. 4:1996;115-123.
30. Schatzberg S., Anderson L., Wilton S.et al. Alternative dystrophin gene transcripts in golden retriever muscular dystrophy. Muscle Nerve. 21:1998;991-998.
31. Nicholson L. The 'rescue' of dystrophin synthesis in boys with Duchenne muscular dystrophy. Neuromuscul Disord. 3:1993;525-531.
32. Kornegay J., Sharp N., Bogan D., Van Camp S., Metcalf J., Schuler R. Contraction tension and kinetics of the peroneus longus muscle in golden retriever muscular dystrophy. J Neurol Sci. 123:1994;100-107.
33. Winnard A., Mendell J., Prior T., Florence J., Burghes A. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am J Hum Genet. 56:1995;158-166.
34. Sherratt T., Vulliamy T., Dubowitz V., Sewry C., Strong P. Exon skipping and translation in patients with frameshift deletions in the dystrophin gene. Am J Hum Genet. 53:1993;1007-1015.
35. Wilton S., Dye D., Laing N. Dystrophin gene transcripts skipping the mdx mutation. Muscle Nerve. 20:1997;728-734.
36. Hoffman E., Morgan J., Watkins S., Partridge T. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J Neurol Sci. 99:1990;9-25.
37. Chelly J., Gilgenkrantz H., Lambert M.et al. Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell. 63:1990;1239-1248.
38. Thanh L.T., Man Nt., Helliwell T., Morris G. Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin. Am J Hum Genet. 56:1995;725-731.
39. Fanin M., Danieli G., Vitiello L., Senter L., Angelini C. Prevalence of dystrophin-positive fibers in 85 Duchenne muscular dystrophy patients. Neuromuscul Disord. 2:1992;41-45.
40. Gussoni E., Blau H., Kunkel L. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med. 3:1997;970-977.
41. Howell J., Fletcher S., Kakulas B., O'Hara M., Lochmuller H., Karpati G. Use of the dog model for Duchenne muscular dystrophy in gene therapy trials. Neuromuscul Disord. 7:1997;325-328.
42. Fassati A., Wells D., Sgro S.P.et al. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells. J Clin Invest. 100:1997;620-628.
43. Rapaport D., Lederfein D., Grootscholten P.et al. Characterization and cell type distribution of a novel, major transcript of the Duchenne muscular dystrophy gene. Differentiation. 49:1992;187-193.
44. D'Souza V., Nguyen T., Morris G., Karges W., Pillers D., Ray P. A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet. 4:1995;837-842.
45. Byers, T., Lidov, H., Kunkel, L. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 1993;4:
46. Lidov H., Selig S., Kunkel L. Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet. 4:1995;329-335.
47. Deconinck N., Tinsley J., Fisher R.et al. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nat Med. 3:1997;1216-1221.
48. Tinsley J., Potter A., Phelps S., Fisher R., Trickett J., Davies K. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene (see comments). Nature. 384:1996;349-353.
49. Pons F., Robert A., Marini J., Leger J. Does utrophin expression in muscles of mdx mice during postnatal development functionally compensate for dystrophin deficiency? J Neurol Sci. 122:1994;162-170.